[1]
Yang C,Montgomery M, Dornase alfa for cystic fibrosis. The Cochrane database of systematic reviews. 2018 Sep 6; [PubMed PMID: 30187450]
[2]
Bobek V,Majewski A,Kolostova K,Rzechonek A,Lischke R,Schutzner J,Kacprzak G, Intrapleural administration of DNase alone for pleural empyema. International journal of clinical and experimental medicine. 2015; [PubMed PMID: 26885174]
[3]
Torbic H,Hacobian G, Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center. Journal of pharmacy practice. 2016 Oct; [PubMed PMID: 25667210]
[4]
Scala M,Hoy D,Bautista M,Palafoutas JJ,Abubakar K, Pilot study of dornase alfa (Pulmozyme) therapy for acquired ventilator-associated infection in preterm infants. Pediatric pulmonology. 2017 Jun; [PubMed PMID: 28052587]
[5]
Nasr SZ,Kuhns LR,Brown RW,Hurwitz ME,Sanders GM,Strouse PJ, Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Pediatric pulmonology. 2001 May; [PubMed PMID: 11340684]
[6]
Mogayzel PJ Jr,Naureckas ET,Robinson KA,Mueller G,Hadjiliadis D,Hoag JB,Lubsch L,Hazle L,Sabadosa K,Marshall B, Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. American journal of respiratory and critical care medicine. 2013 Apr 1; [PubMed PMID: 23540878]
[7]
Rahman NM,Maskell NA,West A,Teoh R,Arnold A,Mackinlay C,Peckham D,Davies CW,Ali N,Kinnear W,Bentley A,Kahan BC,Wrightson JM,Davies HE,Hooper CE,Lee YC,Hedley EL,Crosthwaite N,Choo L,Helm EJ,Gleeson FV,Nunn AJ,Davies RJ, Intrapleural use of tissue plasminogen activator and DNase in pleural infection. The New England journal of medicine. 2011 Aug 11; [PubMed PMID: 21830966]
[8]
Majid A,Kheir F,Folch A,Fernandez-Bussy S,Chatterji S,Maskey A,Fashjian M,Cheng G,Ochoa S,Alape D,Folch E, Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience. Annals of the American Thoracic Society. 2016 Sep; [PubMed PMID: 27333122]
[9]
Bryson HM,Sorkin EM, Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs. 1994 Dec; [PubMed PMID: 7533697]
[10]
Moore BM,Laguna TA,Liu M,McNamara JJ, Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1. Pediatric pulmonology. 2013 Aug; [PubMed PMID: 22997186]